DRKS00005996已完成不适用
European Multinational Prolongation Registry on Prevention of Thromboembolic Events in Atrial Fibrillation - Prolongation PREFER in AF Registry
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 4,171
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •At least 18 years of age;
- •-Written informed consent for participation in the registry;
- •-History of non-valvular AF documented by electrical tracing (ECG, holter, pacemaker, implantable cardioverter defibrillator) within the prior 12 months;
- •-Treated with NOAC or VKA;
排除标准
- •Patients with mechanical valve replacements or moderate, moderately severe or severe mitral stenosis are not allowed to be enrolled.
研究者
相似试验
已完成
不适用
European Multinational Registry on Prevention of Thromboembolic Events in Atrial FibrillatioMedDRA - 10003658 Atrial FibrillationI48.19DRKS00003343Daiichi Sankyo Europe GmbH7,228
已完成
2 期
A Prospective, Multicenter, European Registry Investigating the Lutonix Paclitaxel-Coated Balloon for the Treatment of In-Stent Restenosis within Bare-Metal Stentsrestenotic lesions - stenosis10011082NL-OMON33458utonix20
已完成
4 期
European muLtIcentric Solo International Registryheart valve disease1004697310007593NL-OMON30401Sorin Biomedica Cardio s.r.l.30
招募中
不适用
Real world data on patient management and quality of careCTRI/2021/11/038338AstraZeneca Pharma India Ltd
尚未招募
不适用
An international Multi-Interventional Registry study for chronic ileoAnal pouCh Leaks in UCNL-OMON25472Amsterdam UMC, location AMC1,000